Literature DB >> 8068045

Characterization of peripheral-type benzodiazepine binding sites from rat and pig pancreas.

L Giusti1, L Trincavelli, C Martini, A Lucacchini.   

Abstract

The binding of [3H]1-(2-chlorophenyl-N-methyl-1-methyl-propyl)-3-isoquinolinecarboxa mide ([3H]PK-11195) and [3H]7-chloro-1,3-dihydro-1-methyl-5-(p-chlorophenyl)-2H-1,4-benzodiaz epin-2 - on ([3H]Ro5-4864) to membrane preparations of pancreas was studied in the rat and pig. [3H]PK-11195 bound with high affinity to rat and pig membrane preparations yielding maximal numbers of binding sites (Bmax) of 2393 +/- 160 and 777 +/- 65 fmol/mg of protein, respectively, and equilibrium dissociation constant (Kd) values of 3.01 +/- 0.25 and 3.9 +/- 0.23 nM, respectively. [3H]Ro5-4864 successfully labelled rat but not pig pancreatic membranes, yielding a Kd value of 6.45 +/- 0.5 nM and a Bmax value of 551 +/- 43 fmol/mg of protein. Displacement studies showed a similar rank order of potency of various unlabelled ligands against both [3H]Ro5-4864 and [3H]PK-11195 binding to rat and pig membrane preparations (PK-11195 > or = Ro5-4864 > diazepam > flunitrazepam >> flumazenil). These results suggest that [3H]PK-11195 binds with high affinity and specificity to rat and pig pancreas and [3H]Ro5-4864 binds with high affinity and specificity to rat but not pig pancreas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8068045     DOI: 10.1016/0006-2952(94)90289-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO.

Authors:  Michelle Sexton; Grace Woodruff; Eiron Cudaback; Faith R Kreitzer; Cong Xu; Yi Hsing Lin; Thomas Möller; Mingfeng Bai; H Charles Manning; Darryl Bornhop; Nephi Stella
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

2.  Peripheral type benzodiazepine receptor in human parathyroid glands: up-regulation in adenoma.

Authors:  L Giusti; B Costa; P Viacava; M Castagna; P Iacconi; R E Ricci; M Zaccagnini; P Miccoli; A Lucacchini
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.